Targeting SIRTI By Isoflavone for the Treatment of Type 2 Diabetes and its Complications
Wedi'i Gadw mewn:
Prif Awdur: | Oza Manisha |
---|---|
Fformat: | Traethawd Ymchwil Llyfr |
Iaith: | Saesneg |
Cyhoeddwyd: |
Mumbai
NMIMS-SPPSPTM
2019
|
Pynciau: | |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Preclinical Studies on Daidzein in the Treatment of Diabetic Complications
gan: Laddha Ankit P.
Cyhoeddwyd: (2021) -
Targeting NF-κβ by natural Products in the Management of Vascular Complications of Diabetes
gan: Suryavanshi Sachin Vilas
Cyhoeddwyd: (2021) -
Study of Naturally Occurring Flavones in the Treatment of Vascular Complications of Diabetes
gan: Parkar Nishad
Cyhoeddwyd: (2014) -
Preclinical Studies on Herbal Extract and Phytochemical as Monocyte Chemoattractant Protein-1 (MCP - 1) Inhibitor in Diabetic Complications
gan: Adki Kaveri M.
Cyhoeddwyd: (2023) -
Therapeutic Potential of Beta-Caryophyllene Combined with L-Arginine in the Management of Diabetic Complications
gan: Kumawat Vivek S.
Cyhoeddwyd: (2023)